ZNF143 deletion alters enhancer/promoter looping and CTCF/cohesin geometry
Cell Reports · 2024
DOI: 10.1016/j.celrep.2023.113663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Mo Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Comparative Biomedicine, Ministry of Education Key Laboratory of Systems Biomedicine, State Key Laboratory of Medical Genomics, Institute …. Hauptthemen laut MEDLINE: Cohesins, Chromosomal Proteins, Non-Histone. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Major State Basic Research Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Comparative Biomedicine, Ministry of Education Key Laboratory of Systems Biomedicine, State Key Laboratory of Medical Genomics, Institute of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240…
Förderung
- National Key Research and Development Program of China
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhang, M., Huang, H., Li, J., & Wu, Q. (2024). ZNF143 deletion alters enhancer/promoter looping and CTCF/cohesin geometry. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113663
Vancouver
Zhang M, Huang H, Li J, Wu Q. ZNF143 deletion alters enhancer/promoter looping and CTCF/cohesin geometry. Cell Reports. 2024. doi:10.1016/j.celrep.2023.113663
BibTeX
@article{Zhang2024,
author = {Zhang, Mo and Huang, Haiyan and Li, Jingwei and Wu, Qiang},
title = {ZNF143 deletion alters enhancer/promoter looping and CTCF/cohesin geometry},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2023.113663}
}
EUVIMED